inNOveta Biomedical LLC

Athens, GA · Medtech · Private

Nitric oxide-generating silicone catheters with liquid-infused slippery surfaces to prevent biofilm formation and thrombosis

Grants
$1.3M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$1.0M
2 awards · Health and Human S
#316 of 4531 in medtech
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Health and Human Services · Nitric Oxide Releasing Ultra-slippery Antibacterial$150,000
Federal grantDepartment of Health and Human Services · Phase I · Ultra-low Fouling and Nitric Oxide Releasing Intravascular Catheters for Prevention of Thrombosis and Infection$149,848
Federal contractDepartment of Health and Human Services · Nitric Oxide Releasing Untra-slippery Antibacterial Surfaces For Indwelling Catheter Applications$864,849
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
313Spinefrontier, Inc.$1.0M$2.0M
314VOX BIOMEDICAL LLC$1.0M—
315CREATV MICROTECH INC$1.0M—
316inNOveta Biomedical LLC$1.0M—
317Carrera Bioscience Inc.$1.0M—
318BIOWAVE CORP$1.0M$1.7M
319ZETROZ SYSTEMS LLC$1000K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.